Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndromeSarwa Darwish Murad, Harry L.A. Janssen, Dominique Valla et al.|Hepatology|2004Cited by 358
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, Jianqi Lian et al.|Journal of Hepatology|2020Cited by 346
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationHarry L.A. Janssen, Jordan J. Feld, Harald Hofer et al.|Journal of Hepatology|2016Cited by 273
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*Angelos Hatzakis, Harry L.A. Janssen, Suzanne Wait et al.|Journal of Viral Hepatitis|2011Cited by 234
Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)Willem Pieter Brouwer, Qing Xie, Milan J. Sonneveld et al.|Hepatology|2014Cited by 165